enGene Therapeutics (ENGN) Shares Issued (2022 - 2026)
enGene Therapeutics (ENGN) posted quarterly Shares Issued of $3.9 million for Q2 2026, down 56.56% year-over-year from $9.0 million in Q2 2025, and down 67.46% quarter-over-quarter from $12.1 million in Q1 2026.
enGene Therapeutics (ENGN) Shares Issued (2022 - 2026) Analysis & Trends
enGene Therapeutics (ENGN) has reported Shares Issued for 5 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Issued fell 56.56% year-over-year to $3.9 million; the TTM figure through Apr 2026 stood at $3.9 million (down 56.56% YoY), while the FY2025 annual figure was $9.0 million, up 49.69% from the prior year.
- Shares Issued slipped to $3.9 million in Q2 2026 per ENGN's latest filing, from $12.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $12.1 million in Q1 2026 and bottomed at $1.6 million in Q4 2022.
- Historically, Shares Issued has averaged $6.1 million across 5 years, with a median of $5.0 million in 2024.
- Annual changes were most pronounced in 2025 — Shares Issued surged 281.23% — and 2026, when it tumbled 56.56%.
- enGene Therapeutics' Shares Issued stood at $1.6 million in 2022, then surged by 71.78% to $2.7 million in 2023, then surged by 122.93% to $6.0 million in 2024, then soared by 49.69% to $9.0 million in 2025, then plunged by 56.5% to $3.9 million in 2026.
- Business Quant data shows ENGN's Shares Issued at $3.9 million in Q2 2026, $12.1 million in Q1 2026, and $9.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | - |
| 10 | enGene Therapeutics | 123.76 Mn | 123.76 Mn | - | 12.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.93 Mn |
| Apr 30, 2026 | 3.93 Mn |
| Jan 31, 2026 | 12.08 Mn |
| Jan 31, 2026 | 12.08 Mn |
| Oct 31, 2025 | 9.03 Mn |
| Oct 31, 2025 | 9.03 Mn |
| Jul 31, 2025 | 9.41 Mn |
| Jul 31, 2025 | 9.41 Mn |
| Apr 30, 2025 | 9.05 Mn |
| Apr 30, 2025 | 9.05 Mn |
| Jan 31, 2025 | 9.07 Mn |
| Jan 31, 2025 | 9.07 Mn |
| Oct 31, 2024 | 6.03 Mn |
| Oct 31, 2024 | 6.03 Mn |
| Jul 31, 2024 | 2.47 Mn |
| Jul 31, 2024 | 2.47 Mn |
| Apr 30, 2024 | 3.98 Mn |
| Apr 30, 2024 | 3.98 Mn |
| Jan 31, 2024 | 3.29 Mn |
| Jan 31, 2024 | 3.29 Mn |